Ramy Younes

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +17

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

Olivier Govaere, Simon Cockell, Dina Tiniakos et al. · Science Translational Medicine · 2020 · 454 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +16

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

Arun J. Sanyal, Pierre Bédossa, Mandy Fraessdorf et al. · New England Journal of Medicine · 2024 · 423 citations

Medicine, Pharmacology, Pharmacotherapy +17

Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

Fei Chen, Saeed Esmaili, Geraint B. Rogers et al. · Hepatology · 2019 · 322 citations · Full text

Life Sciences, Biochemistry, Clinical Nutrition +16

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Michèle Vacca, Ioannis Kamzolas, Lea Mørch Harder et al. · Nature Metabolism · 2024 · 229 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17